Evaluation of the sclerotherapeutic efficacy of ethanol, polidocanol, and OK-432 using an in vitro model

Dermatologic Surgery

Volumn 33, Issue 12, 2007, Pages 1452-1459

  Mol, William ^a   Furukawa, Hiroshi ^a   Sasaki, Satoru ^a   Tomaru, Utano ^a   Hayashi, Toshihiko ^a   Saito, Akira ^a   Nagao, Munetomo ^a   Saito, Noriko ^a   Hata, Shinya ^a   Yamamoto, Yuhei ^a,b  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; INTERCELLULAR ADHESION MOLECULE 1; PICIBANIL; POLIDOCANOL; SCLEROSING AGENT;

ARTICLE; CELL CULTURE; CELL DISRUPTION; CELL MEMBRANE; CELL VIABILITY; CONTROLLED STUDY; CYTOLYSIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCLEROSIS; SCLEROTHERAPY; THROMBOEMBOLISM;

CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIAL CELLS; ETHANOL; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MODELS, BIOLOGICAL; PICIBANIL; POLYETHYLENE GLYCOLS; SCLEROSING SOLUTIONS; TREATMENT OUTCOME;

EID: 36749036117     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2007.33315.x     Document Type: Article

References (14)

1. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982 69 : 412 22.
2. Mason KP, Michna E, Juraskowski D, et al. Serum ethanol levels in children and adults after ethanol embolization or sclerotherapy for vascular anomalies. Radiology 2000 217 : 127 32.
3. Marrocco-Trischitta M, Guerrini P, Abeni D, et al. Reversible cardiac arrest after polidocanol sclerotherapy of peripheral venous malformation. Dermatol Surg 2002 28 : 153 5.
4. Ogita S, Tsuto T, Tokiwa K, Takahashi T. Intracystic injection of OK-432: a new sclerosing therapy for cystic hygroma in children. Br J Surg 1987 74 : 690 1.
5. Ogita S, Tsuto T, Nakamura K. OK-432 therapy for lymphangioma in children: why and how does it work? J Pediatr Surg 1996 31 : 477 80.
6. Fukase S, Ohta N, Inamura K, Aoyagi M. Treatment of ranula with intracystic injection of the streptococcal preparation OK-432. Ann Otol Rhinol Laryngol 2003 112 : 214 20.
7. Ishida N, Hoshino T. A Streptococcal Preparation as a Potent Biological Response Modifier OK-432. 2nd ed. Amsterdam : Excerpta Medica 1985. p. 60 2.
8. Okamoto H, Shoin S, Koshimura S, Shimizu R. Studies on the anticancer and streptolysin S-forming abilities of hemolytic streptococci. Jpn J Microbiol 1967 11 : 323 6.
9. Ryoma Y, Moriya Y, Okamoto M, et al. Biological effect of OK-432 (picibanil) and possible application to dendritic cell therapy. Anticancer Res 2004 24 : 3295 301.
10. Kazuei O. Studies on the damage of the cultured endothelial cells and K-562 cells by sclerosants (ethanolamine oleate, aethoxyskerol and absolute ethanol) used for treatment of esophageal varices. J Jpn Soc Gastroenterol 1989 86 : 2365 72.
11. Mackay F, Loetscher H, Stueber D, et al. Tumour necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J Exp Med 1993 177 : 1277 86.
12. Leeuwenberg JF, Smeets EF, Neefjes JJ. E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. Immunology 1992 77 : 543 9.
13. Kanof ME, Smith PD, Zola H. Isolation of whole mononuclear cells from peripheral blood and cord blood. In : Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, editors. Current Protocols in Immunology, Vol. 2. New York : Wiley 1998. p. 7.1.
14. Barth S, Kleinhappl B, Gutschi A, et al. In vitro cytokine mRNA expression in normal human peripheral blood mononuclear cells. Inflam Res 2000 49 : 266 74.